Canadian Pharmacists Association
Canadian Pharmacists Association

Resource Round-up: Opioids & harm reduction

Pharmacists across the country are on the front line of the opioid crisis and are often the first health-care provider to observe signs of opioid use disorder. From assessing new and long-term prescriptions to identifying patients with risk factors and educating patients with harm reduction strategies, pharmacists play a key role balancing safety with decreased pain and overall improvement to quality of life.

Our practice resources related to opioids and harm reduction are designed to support you in your role as an opioid steward.

COVID-19 & CDSA exemptions

During the COVID-19 pandemic, temporary exemptions to the Controlled Drugs and Substances Act (CDSA) were issued to permit pharmacists to extend, renew, adapt, transfer, and deliver opioid-related prescriptions. Over the past year, CPhA has been helping pharmacists navigate these exemptions with the resources in this section.

Naloxone

These practice tools are intended to support patient education. Share this information with your community as supplementary information to counselling and education programs on preventing overdose deaths.

Opioid stewardship

Pharmacists in the spotlight

 

 

A pharmacist’s story

Meet Craig Plain, a Vancouver pharmacist on the frontlines of the opioid crisis. His unique practice brings him out from behind the pharmacy counter and into the community to help his patients.

For more evidence, resources, and advocacy tools supporting a harmonized scope of practice for pharmacists to better manage opioid therapy, you can also visit the Pharmacists Opioid Stewardship Initiative (POSI), part of the Canadian Pharmacists’ Harmonized Scope (CPHS) project.


Our Resource Round-up series gathers our available resources and practice tools on important health topics to help you in your practice. Check out our other Resource Round-ups on topics like Mental Health and Women’s Health.

Last updated on August 30, 2021